Author reply to "Heterologous mRNA-based COVID-19 booster strategies: Comment"

被引:0
|
作者
Das, Rituparna [1 ,3 ]
Hyer, Randall N. [2 ]
Burton, Paul [1 ]
Miller, Jacqueline M. [1 ]
Kuter, Barbara J. [1 ]
机构
[1] Moderna Inc, Cambridge, MA USA
[2] Baruch S Blumberg Inst, Doylestown, PA USA
[3] Moderna Inc, 200 Technol Sq, Cambridge, MA 02139 USA
关键词
D O I
10.1080/21645515.2023.2195333
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Heterologous mRNA-based COVID-19 booster strategies: Comment
    Yasri, Sora
    Wiwanitkit, Viroj
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [2] Emerging heterologous mRNA-based booster strategies within the COVID-19 vaccine landscape
    Das, Rituparna
    Hyer, Randall N.
    Burton, Paul
    Miller, Jacqueline M.
    Kuter, Barbara J.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [3] Booster Doses of mRNA-Based COVID-19 Vaccines for All Adults
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1640): : 201 - 202
  • [4] Reply to "Myocarditis following mRNA-Based COVID-19 Vaccines: Correspondence"
    Kask, Lauri
    Larsen, Terje H.
    Rajani, Ronak
    Saeed, Sahrai
    CARDIOLOGY, 2022, 147 (04) : 419 - 420
  • [5] Immune response to mRNA-based COVID-19 booster vaccination in people living with HIV
    Malin, Jakob J.
    Suarez, Isabelle
    Biehl, Lena M.
    Schommers, Philipp
    Knops, Elena
    Di Cristanziano, Veronica
    Heger, Eva
    Pflieger, Eva
    Wyen, Christoph
    Bettin, Daniel
    Rybniker, Jan
    Faetkenheuer, Gerd
    Lehmann, Clara
    HIV MEDICINE, 2023, 24 (07) : 785 - 793
  • [6] Immune response to mRNA-based COVID-19 booster vaccination in people living with HIV
    Malin, Jakob J.
    Suarez, Isabelle
    Biehl, Lena
    Schommers, Phillip
    Knops, Elena
    Di Cristanziano, Veronica
    Heger, Eva
    Pflieger, Eva
    Wyen, Christoph
    Bettin, Daniel
    Rybniker, Jan
    Faetkenheuer, Gerd
    Lehmann, Clara
    HIV MEDICINE, 2023, 24 : 78 - 79
  • [7] Booster Effect of a Third mRNA-Based COVID-19 Vaccine Dose in Patients with Myeloid Malignancies
    Mori, Akio
    Onozawa, Masahiro
    Kobayashi, Mirei
    Tsukamoto, Shihori
    Senjo, Hajime
    Ishio, Takashi
    Yokoyama, Emi
    Izumiyama, Koh
    Saito, Makoto
    Muraki, Haruna
    Morioka, Masanobu
    Teshima, Takanori
    Kondo, Takeshi
    BLOOD, 2022, 140 : 9781 - 9782
  • [8] Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US Reply
    Oster, Matthew E.
    Shay, David K.
    Shimabukuro, Tomt.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (20): : 2020 - 2021
  • [9] mRNA-based COVID-19 booster vaccination is highly effective and cost-effective in Australia
    Li, Rui
    Liu, Hanting
    Fairley, Christopher K.
    Ong, Jason
    Guo, Yuming
    Lu, Pengyi
    Zou, Zhuoru
    Xie, Li
    Zhuang, Guihua
    Li, Yan
    Shen, Mingwang
    Zhang, Lei
    VACCINE, 2023, 41 (15) : 2439 - 2446
  • [10] Booster effect of a third mRNA-based COVID-19 vaccine dose in patients with myeloid malignancies
    Mori, Akio
    Onozawa, Masahiro
    Kobayashi, Mirei
    Tsukamoto, Shihori
    Senjo, Hajime
    Ishio, Takashi
    Yokoyama, Emi
    Kanaya, Minoru
    Izumiyama, Koh
    Saito, Makoto
    Muraki, Haruna
    Morioka, Masanobu
    Teshima, Takanori
    Kondo, Takeshi
    CANCER MEDICINE, 2023, 12 (16): : 16881 - 16888